- Home
- PCB vs STRO Comparison
PCB vs STRO Comparison
Compare PCB & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PCB | STRO |
|---|---|---|
| Founded | 2003 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 325.6M | 85.0M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | PCB | STRO |
|---|---|---|
| Price | $21.53 | $11.64 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 8 |
| Target Price | ★ $24.50 | $18.29 |
| AVG Volume (30 Days) | 27.1K | ★ 129.5K |
| Earning Date | 01-29-2026 | 11-06-2025 |
| Dividend Yield | ★ 3.67% | N/A |
| EPS Growth | ★ 43.50 | N/A |
| EPS | ★ 2.41 | N/A |
| Revenue | ★ $107,743,000.00 | $105,646,000.00 |
| Revenue This Year | $21.55 | $63.08 |
| Revenue Next Year | $8.65 | N/A |
| P/E Ratio | $9.05 | ★ N/A |
| Revenue Growth | ★ 13.61 | N/A |
| 52 Week Low | $16.00 | $5.23 |
| 52 Week High | $24.04 | $21.50 |
Technical Indicators
Market Signals| Indicator | PCB | STRO |
|---|---|---|
| Relative Strength Index (RSI) | 42.06 | 79.57 |
| Support Level | $23.03 | $8.49 |
| Resistance Level | $24.04 | $12.00 |
| Average True Range (ATR) | 0.64 | 0.86 |
| MACD | -0.21 | -0.02 |
| Stochastic Oscillator | 9.49 | 85.95 |
Price Performance
Historical ComparisonAbout PCB PCB Bancorp
PCB Bancorp is a bank holding company, which engages in the provision of consumer and commercial banking services. It provides Personal, Business, and Loan services, which provide banking, lending, and digital, tools, home loans, and others. Also, it offers a broad range of loans, deposits, and other products and services predominantly to small and middle-market businesses and individuals. The company provided it's services in Los Angeles and Orange Counties, California; Bellevue, Washington; and Atlanta, Georgia.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.